Ipca Laboratories Ltd

Earnings Call

Ipca Laboratories Earnings Call Transcript: Key Takeaways

Ipca reported strong Q1FY27 with 21% consolidated revenue growth and EBITDA margins expanding 449bps to 22.88%. Management raised full-year growth and margin guidance based on robust generic and domestic performance.

Call

Guides 16% growth

Financial ResultsAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Ipca Laboratories Q1 FY27 Results: Net Profit ₹424.3 Cr, Up 82.2% YoY

Ipca Laboratories Ltd reported revenue from operations of ₹2,788 Cr (+20.8% YoY) and net profit of ₹424.3 Cr (+82.2% YoY) for Q1 FY27.

Key figure

Net profit ₹424.3 Cr · +82.2% YoY

Earnings Call

Ipca Laboratories Earnings Call: Key Takeaways

Ipca Labs reports 8% FY26 consolidated revenue growth to ₹9,646cr. Management focuses on margin improvement and volume-led growth in domestic and US markets.

Financial Results

Ipca Laboratories Q4 FY26 Results: Net Profit ₹306.7 Cr, Up 379.2% YoY

Ipca Laboratories Ltd reported revenue from operations of ₹2,388 Cr (+6.3% YoY) and net profit of ₹306.7 Cr (+379.2% YoY) for Q4 FY26.

Key figure

Net profit ₹306.7 Cr · +379.2% YoY